BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND PDCD1, CD279, PD-1, PD1, SLEB2, hPD-1, hPD-l, hSLE1 AND Diagnosis
176 results:

  • 1. Recognizing puzzling pd1 + infiltrates in marginal zone lymphoma by integrating clonal and mutational findings: pitfalls in both nodal and transformed splenic cases.
    Deng J; Cao Y; Diao X; Wu M; Li X; Shi Y
    Diagn Pathol; 2023 Dec; 18(1):134. PubMed ID: 38082447
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Tumor microenvironment in Hodgkin lymphoma: novel prognostic factors for assessing disease evolution.
    Turbatu A; Dobrea C; Stoian M; Barta CT; Halcu G; Birceanu A; Bordea AM; Ghimici CG; Oprea MM; Neacșu LD; Lupu AR; Coliță A
    J Med Life; 2023 Aug; 16(8):1201-1210. PubMed ID: 38024830
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Tissue Eosinophilia in B-cell lymphoma: An Underrecognized Phenomenon.
    Zhou T; Wang HW; Ng SB; Summers T; Xi L; Raffeld M; Pittaluga S; Jaffe ES
    Am J Surg Pathol; 2024 Apr; 48(4):426-436. PubMed ID: 37988030
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Expression of pd-1/PD-L1 in peripheral blood and tumor tissues of patients with classical Hodgkin's lymphoma.
    Feng X; Luo X; Yang Y; Fan Y; Ye Q
    Medicine (Baltimore); 2023 Nov; 102(44):e35757. PubMed ID: 37933048
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. pd-1 expression on tumour-infiltrating cells is a prognostic factor for relapsed or refractory diffuse large B-cell lymphoma.
    Wada F; Kamijo K; Shimomura Y; Yamashita D; Hara S; Ishikawa T
    Immunology; 2024 Feb; 171(2):224-234. PubMed ID: 37904615
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Progressively transformed germinal center-like follicular T-cell lymphoma:a clinicopathological analysis of 14 cases].
    Zheng YY; Xie JL; Zhang YL; Zhou XG
    Zhonghua Bing Li Xue Za Zhi; 2023 Nov; 52(11):1144-1150. PubMed ID: 37899321
    [No Abstract]    [Full Text] [Related]  

  • 7. Critical Review-A Tribute to Louis Brocq lymphomatoid Papulosis, the Key in Exploring the Relationship of Parapsoriasis and Mycosis Fungoides.
    Kossard S
    Am J Dermatopathol; 2023 Nov; 45(11):753-761. PubMed ID: 37782018
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Accelerated Chronic Lymphocytic Leukemia and Richter Transformation in the Era of Novel Agents.
    Levy Yurkovski I; Tadmor T
    Acta Haematol; 2024; 147(1):73-83. PubMed ID: 37666234
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Programmed Death 1 (pd-1) Expression in Relapsing and Remitting Hodgkin lymphoma as Prognostic Factor.
    Bouzari B; Basi A; Dadkhah S; Panahi M; Mohammadi S
    Asian Pac J Cancer Prev; 2023 Aug; 24(8):2829-2835. PubMed ID: 37642071
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Pediatric T-cell acute lymphoblastic leukemia blast signature and MRD associated immune environment changes defined by single cell transcriptomics analysis.
    Bhasin SS; Thomas BE; Summers RJ; Sarkar D; Mumme H; Pilcher W; Emam M; Raikar SS; Park SI; Castellino SM; Graham DK; Bhasin MK; DeRyckere D
    Sci Rep; 2023 Aug; 13(1):12556. PubMed ID: 37532715
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Pathology for severe inflammatory PML with pd1/PD-L1 expression of favorable prognosis: What's a prognostic factor for PML-IRIS?
    Shishido-Hara Y; Akimoto J; Fukami S; Kohno M; Matsubayashi J; Nagao T
    Neuropathology; 2024 Feb; 44(1):47-58. PubMed ID: 37424276
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Follicular lymphoma Microenvironment Traits Associated with Event-Free Survival.
    Tumedei MM; Piccinini F; Azzali I; Pirini F; Bravaccini S; De Matteis S; Agostinelli C; Castellani G; Zanoni M; Cortesi M; Vergani B; Leone BE; Righi S; Gazzola A; Casadei B; Gentilini D; Calzari L; Limarzi F; Sabattini E; Pession A; Tazzari M; Bertuzzi C
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373066
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Pembrolizumab-induced optic neuropathy - a case report.
    Daetwyler E; Zippelius A; Meyer P; Läubli H
    Front Immunol; 2023; 14():1171981. PubMed ID: 37228591
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Allogeneic hematopoietic stem cell transplantation for NK/T-cell lymphoma: an international collaborative analysis.
    Berning P; Schmitz N; Ngoya M; Finel H; Boumendil A; Wang F; Huang XJ; Hermine O; Philippe L; Couronné L; Jaccard A; Liu D; Wu D; Reinhardt HC; Chalandon Y; Wagner-Drouet E; Kwon M; Zhang X; Carpenter B; Yakoub-Agha I; Wulf G; López-Jiménez J; Sanz J; Labussière-Wallet H; Shimoni A; Dreger P; Sureda A; Kim WS; Glass B
    Leukemia; 2023 Jul; 37(7):1511-1520. PubMed ID: 37157017
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Deciphering the spectrum of cutaneous lymphomas expressing TFH markers.
    Donzel M; Trecourt A; Balme B; Harou O; Mauduit C; Bachy E; Guesquières H; Fontaine J; Ortonne N; Perier-Muzet M; Dalle S; Traverse-Glehen A
    Sci Rep; 2023 Apr; 13(1):6500. PubMed ID: 37081015
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Follicular Helper T-Cell-derived Nodal lymphomas: Study of Histomorphologic, Immunophenotypic, Clinical, and RHOA G17V Mutational Profile.
    Jain S; Goswami A; Lone MR; Ramteke P; Gogia A; Aggarwal M; Viswanathan GK; Kakkar D; Mandal T; Sharma A; Sahoo R; Baldia A; Sharma MC; Bakhshi S; Pramanik R; Dhawan R; Kumar L; Mallick S
    Appl Immunohistochem Mol Morphol; 2023 Mar; 31(3):172-180. PubMed ID: 36806188
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Coexpression of PD-L1/pd-1 with CXCR3/CD36 and IL-19 Increase in Extranodal lymphoma.
    Saber MM
    J Immunol Res; 2023; 2023():4556586. PubMed ID: 36726488
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Use of Checkpoint Inhibitors in Gray Zone lymphoma.
    Rosales YMZ; Mesquita JL; Garcia YDO; Paz FRF; Campos NCB; Leitão JPV; Filho FDR; Filho RVAO; Lemes RPG; Duarte FB
    Hematol Oncol Stem Cell Ther; 2023 Jan; 16(1):315-319. PubMed ID: 36634274
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Association of TIM-3 checkpoint receptor expression on T cells with treatment-free remission in chronic myeloid leukemia.
    Irani YD; Kok CH; Clarson J; Shanmuganathan N; Branford S; Yeung DT; Ross DM; Hughes TP; Yong ASM
    Blood Adv; 2023 Jun; 7(11):2364-2374. PubMed ID: 36622326
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Classic Hodgkin lymphoma with marked granulomatous reaction: A clinicopathologic study of 20 cases.
    Xu J; Li S; Yin CC; Patel KP; Tang G; Wang W; Miranda RN; Garces S; Tang Z; Lin P; Medeiros LJ
    Hum Pathol; 2023 Apr; 134():114-123. PubMed ID: 36584716
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 9.